Sign In
Buy JAZZ
$240.06
+9.13 (+3.95%)
At Close: Jun 04, 2026
Why Jazz (JAZZ) is Poised to Beat Earnings Estimates Again
01:50pm, Tuesday, 01'st Feb 2022
Jazz (JAZZ) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
2 Top Cannabis Stocks to Buy For the Long Haul
10:14am, Monday, 31'st Jan 2022 The Motley Fool
These are two of the best options to profit from the rapidly growing marijuana industry.
2 Top Cannabis Stocks to Buy For the Long Haul
05:14am, Monday, 31'st Jan 2022
These are two of the best options to profit from the rapidly growing marijuana industry.
The "Cannabis 50" List For 2021 Is Out, Is Your Favorite Company On It?
09:27pm, Friday, 28'th Jan 2022 Benzinga
MGO (Macias Gini and O’Connell LLP), a leader in accounting, tax, audit and advisory solutions for the cannabis and hemp industries has released its 3rd annual “Cannabis 50” list.
The list high
Jim Cramer Shares His Thoughts On ArcBest, Ulta Beauty And More
01:36pm, Thursday, 27'th Jan 2022 Benzinga
On CNBC’s "Mad Money Lightning Round," Jim Cramer said he likes ArcBest Corporation (NASDAQ: ARCB). Yet with Union Pacific Corporation (NYSE: UNP) having a really good intermodal business, he recomm
Jazz Pharmaceuticals (JAZZ) Presents At 40th Annual J.P. Morgan Virtual Healthcare Conference
04:50pm, Monday, 24'th Jan 2022 Seeking Alpha
3 Top Biotech Stock Picks For 2022, According To This Needham Analyst
08:58pm, Friday, 21'st Jan 2022 Benzinga
Following recent updates from numerous management teams within the health care space, Needham analyst Ami Fadia has reevaluated the stocks in the firm's coverage universe using a stock selection crit
Zogenix (ZGNX) Stock Surges on Acquisition Offer From UCB
04:28pm, Thursday, 20'th Jan 2022 Zacks Investment Research
Belgium-based UCB is set to acquire Zogenix (ZGNX) for a total transaction value of $1.9 billion in cash. The transaction is likely to be completed by second-quarter 2022.
Can Jazz (JAZZ) Climb 41% to Reach the Level Wall Street Analysts Expect?
03:00pm, Monday, 17'th Jan 2022 Zacks Investment Research
The average of price targets set by Wall Street analysts indicates a potential upside of 41.5% in Jazz (JAZZ). While the effectiveness of this highly sought-after metric is questionable, the positive
Can Jazz (JAZZ) Climb 41% to Reach the Level Wall Street Analysts Expect?
11:36am, Monday, 17'th Jan 2022
The average of price targets set by Wall Street analysts indicates a potential upside of 41.5% in Jazz (JAZZ). While the effectiveness of this highly sought-after metric is questionable, the positive
Report: Global Cannabis Beverages Market Expected To Reach $2B By 2026
09:07pm, Friday, 14'th Jan 2022 Benzinga
As the COVID-19 pandemic continues, the global market for cannabis beverages estimated at $799.8 million 2020, is projected to reach a revised size of $2 billion by 2026, growing at a CAGR of 16.9%,
2 Stocks to Buy No Matter What Happens in 2022
04:15pm, Friday, 14'th Jan 2022 The Motley Fool
One of the keys to winning in the stock market is to ignore short-term issues and volatility.
2 Stocks to Buy No Matter What Happens in 2022
11:15am, Friday, 14'th Jan 2022
One of the keys to winning in the stock market is to ignore short-term issues and volatility.
Why Jazz Pharmaceuticals Sank 23% in 2021
03:46pm, Tuesday, 11'th Jan 2022 The Motley Fool
The biotech was beaten down despite a highly promising future.
Why Jazz Pharmaceuticals Sank 23% in 2021
10:46am, Tuesday, 11'th Jan 2022
The biotech was beaten down despite a highly promising future.
